The effect of neoadjuvant chemoradiation therapy in resectable pancreatic cancer was independent of intratumoral vascularization
The histopathological efficacy of NACRT for resectable PC did not differ significantly on the basis of enhancement pattern observed on CH-EUS. NACRT may provide additional therapeutic benefit independent of blood flow considerations.
Authors
- Shigenori Nagata (ORCID: https://orcid.org/0000-0002-5455-6886)
- Hirofumi Akita (ORCID: https://orcid.org/0000-0002-3115-9466)
- Ryoji Takada (ORCID: https://orcid.org/0000-0002-6568-8091)
- Tomomi Yasue (ORCID: https://orcid.org/0009-0005-6343-5890)
- Kenji Ikezawa (ORCID: https://orcid.org/0000-0001-7517-8960)
- Kazuyoshi Ohkawa (ORCID: https://orcid.org/0000-0001-9700-2472)
- Hidenori Takahashi (ORCID: https://orcid.org/0000-0003-4801-3540)
- Hidetoshi Eguchi (ORCID: https://orcid.org/0000-0002-2318-1129)
- Reiko Ashida (ORCID: https://orcid.org/0000-0002-6918-3066)
- Teruki Teshima
- Yuichiro Doki
Institutions
- Wakayama Medical University (JP)
- Osaka Prefectural Medical Center (JP)
- Fukuoka Tokushukai Hospital (JP)
- Osaka International Cancer Institute (JP)
- Osaka International Cancer Institute (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-07-19
- DOI
- https://doi.org/10.1186/s12876-025-04108-2
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00